Jiangsu Hengrui Medicine (600276.SS) Revenue
Market Cap: $314.93B
Avg Volume: 48.59M
Industry: Drug Manufacturers - General
Sector: Healthcare
What is Jiangsu Hengrui Medicine 's Revenue?
Jiangsu Hengrui Medicine 's quarterly revenue as of Q1 2025 is $7.21B.
Jiangsu Hengrui Medicine 's annual revenue for the fiscal year 2024 is $27.98B.
Related metrics for Jiangsu Hengrui Medicine (quarterly):
- Cost of Revenue: $1.07B
- Gross Profit: $6.14B
- Gross Profit Ratio: 85.17%
- Revenue Per Share: $1.15
- Revenue Growth: -7.56%
Apple's quarterly revenue was $7.21B, with a cost of revenue of $1.07B, which leaves $6.14B gross profit and a gross profit ratio of 85.17%.
Related metrics for Jiangsu Hengrui Medicine (annual):
- Cost of Revenue: $3.85B
- Gross Profit: $24.14B
- Gross Profit Ratio: 86.25%
- Revenue Per Share: $4.42
- Revenue Growth: 22.63%
Apple's annual revenue was $27.98B, with a cost of revenue of $3.85B, which leaves $24.14B gross profit and a gross profit ratio of 86.25%.
Understanding Revenue
Revenue is the total amount of income generated by the sale of goods or services related to the company's primary operations. It is often referred to as the "top line" because it sits at the top of the income statement.
End of Year Revenue
The table below shows the revenue for each fiscal year, with the latest data available for 2024.
| Year | Revenue | Change |
|---|---|---|
| 2024 | $27.98B | 22.63% |
| 2023 | $22.82B | 7.26% |
| 2022 | $21.28B | -17.87% |
| 2021 | $25.91B | -6.59% |
| 2020 | $27.73B | 19.09% |
| 2019 | $23.29B | 33.70% |
| 2018 | $17.42B | 25.89% |
| 2017 | $13.84B | 24.72% |
| 2016 | $11.09B | 19.08% |
| 2015 | $9.32B | 25.01% |
| 2014 | $7.45B | 20.14% |
| 2013 | $6.20B | 14.13% |
| 2012 | $5.44B | 19.44% |
| 2011 | $4.55B | 21.53% |
| 2010 | $3.74B | 23.61% |
| 2009 | $3.03B | 26.60% |
| 2008 | $2.39B | 22.09% |
| 2007 | $1.96B | 37.77% |
| 2006 | $1.42B | 20.62% |
| 2005 | $1.18B | 2.98% |
| 2004 | $1.15B | 9.02% |
| 2003 | $1.05B | 38.93% |
| 2002 | $756.03M | 19.20% |
| 2001 | $634.27M | 30.86% |
| 2000 | $484.71M | 17.10% |
| 1999 | $413.93M | 13.78% |
| 1998 | $363.79M | 19.84% |
| 1997 | $303.57M | N/A |
Related Metrics
Explore detailed financial metrics and analysis for 600276.SS.